 | • レポートコード：GIR201106147 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、臓器移植免疫抑制剤の世界市場を調査対象にし、臓器移植免疫抑制剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他）、用途別分析（肝移植、腎移植、心臓移植、その他臓器移植）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Roche、Genzyme、Novartis、Astellas Pharma Inc.、Cilag、Huadong Pharmaceutical、North China Pharmaceutical Group Corporation、Cinkate Corporation、Catalent Pharma、Changzhou Pharm、SL PHARM、Livzon Pharmaceutical Group Inc.,、Sirio Pharma Co., Ltd ・メーカー別販売量、売上、市場シェア ・臓器移植免疫抑制剤の地域別市場分析 ・臓器移植免疫抑制剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・臓器移植免疫抑制剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・臓器移植免疫抑制剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・臓器移植免疫抑制剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・臓器移植免疫抑制剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・臓器移植免疫抑制剤の種類別市場規模2015-2020：タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他 ・臓器移植免疫抑制剤の用途別市場規模2015-2020：肝移植、腎移植、心臓移植、その他臓器移植 ・臓器移植免疫抑制剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Organ Transplant Immunosuppressant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Organ Transplant Immunosuppressant sales will be xx in 2020 from Organ Transplant Immunosuppressant million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Organ Transplant Immunosuppressant market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Organ Transplant Immunosuppressant industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Organ Transplant Immunosuppressant and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Organ Transplant Immunosuppressant market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Organ Transplant Immunosuppressant market has been segmented into
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
By Application, Organ Transplant Immunosuppressant has been segmented into:
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Organ Transplant Immunosuppressant market presented in the report. This section sheds light on the sales growth of different regional and country-level Organ Transplant Immunosuppressant markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Organ Transplant Immunosuppressant market.
The report offers in-depth assessment of the growth and other aspects of the Organ Transplant Immunosuppressant market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Organ Transplant Immunosuppressant Market Share Analysis
Organ Transplant Immunosuppressant competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Organ Transplant Immunosuppressant sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Organ Transplant Immunosuppressant sales, revenue and market share for each player covered in this report.
The major players covered in Organ Transplant Immunosuppressant are:
Roche
Genzyme
Novartis
Astellas Pharma Inc.
Cilag
Huadong Pharmaceutical
North China Pharmaceutical Group Corporation
Cinkate Corporation
Catalent Pharma
Changzhou Pharm
SL PHARM
Livzon Pharmaceutical Group Inc.,
Sirio Pharma Co., Ltd
Among other players domestic and global, Organ Transplant Immunosuppressant market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Organ Transplant Immunosuppressant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Organ Transplant Immunosuppressant, with price, sales, revenue and global market share of Organ Transplant Immunosuppressant in 2018 and 2019.
Chapter 3, the Organ Transplant Immunosuppressant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Organ Transplant Immunosuppressant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Organ Transplant Immunosuppressant market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Organ Transplant Immunosuppressant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Organ Transplant Immunosuppressant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Organ Transplant Immunosuppressant Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tacrolimus
1.2.3 Mycophenolate Mofetil
1.2.4 Cyclosporin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Organ Transplant Immunosuppressant Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Liver Transplant
1.3.3 Kidney Transplant
1.3.4 Heart Transplant
1.3.5 Other Organ Transplant
1.4 Overview of Global Organ Transplant Immunosuppressant Market
1.4.1 Global Organ Transplant Immunosuppressant Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Organ Transplant Immunosuppressant Industry Impact
1.6.1 COVID-19 Potential Implications for the Organ Transplant Immunosuppressant
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Organ Transplant Immunosuppressant
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genzyme
2.2.1 Genzyme Details
2.2.2 Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genzyme SWOT Analysis
2.2.4 Genzyme Product and Services
2.2.5 Genzyme Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma Inc.
2.4.1 Astellas Pharma Inc. Details
2.4.2 Astellas Pharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma Inc. SWOT Analysis
2.4.4 Astellas Pharma Inc. Product and Services
2.4.5 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cilag
2.5.1 Cilag Details
2.5.2 Cilag Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cilag SWOT Analysis
2.5.4 Cilag Product and Services
2.5.5 Cilag Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Huadong Pharmaceutical
2.6.1 Huadong Pharmaceutical Details
2.6.2 Huadong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Huadong Pharmaceutical SWOT Analysis
2.6.4 Huadong Pharmaceutical Product and Services
2.6.5 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 North China Pharmaceutical Group Corporation
2.7.1 North China Pharmaceutical Group Corporation Details
2.7.2 North China Pharmaceutical Group Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 North China Pharmaceutical Group Corporation SWOT Analysis
2.7.4 North China Pharmaceutical Group Corporation Product and Services
2.7.5 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cinkate Corporation
2.8.1 Cinkate Corporation Details
2.8.2 Cinkate Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Cinkate Corporation SWOT Analysis
2.8.4 Cinkate Corporation Product and Services
2.8.5 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Catalent Pharma
2.9.1 Catalent Pharma Details
2.9.2 Catalent Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Catalent Pharma SWOT Analysis
2.9.4 Catalent Pharma Product and Services
2.9.5 Catalent Pharma Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Changzhou Pharm
2.10.1 Changzhou Pharm Details
2.10.2 Changzhou Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Changzhou Pharm SWOT Analysis
2.10.4 Changzhou Pharm Product and Services
2.10.5 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 SL PHARM
2.11.1 SL PHARM Details
2.11.2 SL PHARM Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 SL PHARM SWOT Analysis
2.11.4 SL PHARM Product and Services
2.11.5 SL PHARM Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Livzon Pharmaceutical Group Inc.,
2.12.1 Livzon Pharmaceutical Group Inc., Details
2.12.2 Livzon Pharmaceutical Group Inc., Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Livzon Pharmaceutical Group Inc., SWOT Analysis
2.12.4 Livzon Pharmaceutical Group Inc., Product and Services
2.12.5 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sirio Pharma Co., Ltd
2.13.1 Sirio Pharma Co., Ltd Details
2.13.2 Sirio Pharma Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sirio Pharma Co., Ltd SWOT Analysis
2.13.4 Sirio Pharma Co., Ltd Product and Services
2.13.5 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Organ Transplant Immunosuppressant Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Organ Transplant Immunosuppressant Manufacturer Market Share in 2019
3.3.2 Top 6 Organ Transplant Immunosuppressant Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Regions
4.1.1 Global Organ Transplant Immunosuppressant Sales and Market Share by Regions (2015-2020)
4.1.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Regions (2015-2020)
4.2 North America Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
4.3 Europe Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
4.5 South America Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Country
5.1.1 North America Organ Transplant Immunosuppressant Sales and Market Share by Country (2015-2020)
5.1.2 North America Organ Transplant Immunosuppressant Revenue and Market Share by Country (2015-2020)
5.2 United States Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
5.3 Canada Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
5.4 Mexico Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Country
6.1.1 Europe Organ Transplant Immunosuppressant Sales and Market Share by Country (2015-2020)
6.1.2 Europe Organ Transplant Immunosuppressant Revenue and Market Share by Country (2015-2020)
6.2 Germany Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
6.3 UK Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
6.4 France Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
6.5 Russia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
6.6 Italy Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Organ Transplant Immunosuppressant Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Organ Transplant Immunosuppressant Revenue and Market Share by Regions (2015-2020)
7.2 China Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7.3 Japan Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7.4 Korea Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7.5 India Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
7.7 Australia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Country
8.1.1 South America Organ Transplant Immunosuppressant Sales and Market Share by Country (2015-2020)
8.1.2 South America Organ Transplant Immunosuppressant Revenue and Market Share by Country (2015-2020)
8.2 Brazil Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
8.3 Argentina Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Organ Transplant Immunosuppressant Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Organ Transplant Immunosuppressant Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Organ Transplant Immunosuppressant Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
9.3 Turkey Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
9.4 Egypt Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
9.5 South Africa Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Organ Transplant Immunosuppressant Sales and Market Share by Type (2015-2020)
10.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Type (2015-2020)
10.3 Global Organ Transplant Immunosuppressant Price by Type (2015-2020)
11 Global Organ Transplant Immunosuppressant Market Segment by Application
11.1 Global Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
11.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2015-2020)
11.3 Global Organ Transplant Immunosuppressant Price by Application (2015-2020)
12 Market Forecast
12.1 Global Organ Transplant Immunosuppressant Sales, Revenue and Growth Rate (2021-2025)
12.2 Organ Transplant Immunosuppressant Market Forecast by Regions (2021-2025)
12.2.1 North America Organ Transplant Immunosuppressant Market Forecast (2021-2025)
12.2.2 Europe Organ Transplant Immunosuppressant Market Forecast (2021-2025)
12.2.3 Asia-Pacific Organ Transplant Immunosuppressant Market Forecast (2021-2025)
12.2.4 South America Organ Transplant Immunosuppressant Market Forecast (2021-2025)
12.2.5 Middle East & Africa Organ Transplant Immunosuppressant Market Forecast (2021-2025)
12.3 Organ Transplant Immunosuppressant Market Forecast by Type (2021-2025)
12.3.1 Global Organ Transplant Immunosuppressant Sales Forecast by Type (2021-2025)
12.3.2 Global Organ Transplant Immunosuppressant Market Share Forecast by Type (2021-2025)
12.4 Organ Transplant Immunosuppressant Market Forecast by Application (2021-2025)
12.4.1 Global Organ Transplant Immunosuppressant Sales Forecast by Application (2021-2025)
12.4.2 Global Organ Transplant Immunosuppressant Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Organ Transplant Immunosuppressant Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Organ Transplant Immunosuppressant Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Organ Transplant Immunosuppressant Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Organ Transplant Immunosuppressant Major Business
Table 10. Roche Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 11. Roche SWOT Analysis
Table 12. Roche Organ Transplant Immunosuppressant Product and Services
Table 13. Roche Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Genzyme Basic Information, Manufacturing Base and Competitors
Table 15. Genzyme Organ Transplant Immunosuppressant Major Business
Table 16. Genzyme Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 17. Genzyme SWOT Analysis
Table 18. Genzyme Organ Transplant Immunosuppressant Product and Services
Table 19. Genzyme Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Novartis Basic Information, Manufacturing Base and Competitors
Table 21. Novartis Organ Transplant Immunosuppressant Major Business
Table 22. Novartis Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 23. Novartis SWOT Analysis
Table 24. Novartis Organ Transplant Immunosuppressant Product and Services
Table 25. Novartis Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 27. Astellas Pharma Inc. Organ Transplant Immunosuppressant Major Business
Table 28. Astellas Pharma Inc. Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 29. Astellas Pharma Inc. SWOT Analysis
Table 30. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product and Services
Table 31. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Cilag Basic Information, Manufacturing Base and Competitors
Table 33. Cilag Organ Transplant Immunosuppressant Major Business
Table 34. Cilag Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 35. Cilag SWOT Analysis
Table 36. Cilag Organ Transplant Immunosuppressant Product and Services
Table 37. Cilag Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Huadong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Huadong Pharmaceutical Organ Transplant Immunosuppressant Major Business
Table 40. Huadong Pharmaceutical Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 41. Huadong Pharmaceutical SWOT Analysis
Table 42. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product and Services
Table 43. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 45. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Major Business
Table 46. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 47. North China Pharmaceutical Group Corporation SWOT Analysis
Table 48. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product and Services
Table 49. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Cinkate Corporation Basic Information, Manufacturing Base and Competitors
Table 51. Cinkate Corporation Organ Transplant Immunosuppressant Major Business
Table 52. Cinkate Corporation Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 53. Cinkate Corporation SWOT Analysis
Table 54. Cinkate Corporation Organ Transplant Immunosuppressant Product and Services
Table 55. Cinkate Corporation Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Catalent Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Catalent Pharma Organ Transplant Immunosuppressant Major Business
Table 58. Catalent Pharma Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 59. Catalent Pharma SWOT Analysis
Table 60. Catalent Pharma Organ Transplant Immunosuppressant Product and Services
Table 61. Catalent Pharma Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Changzhou Pharm Basic Information, Manufacturing Base and Competitors
Table 63. Changzhou Pharm Organ Transplant Immunosuppressant Major Business
Table 64. Changzhou Pharm Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 65. Changzhou Pharm SWOT Analysis
Table 66. Changzhou Pharm Organ Transplant Immunosuppressant Product and Services
Table 67. Changzhou Pharm Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. SL PHARM Basic Information, Manufacturing Base and Competitors
Table 69. SL PHARM Organ Transplant Immunosuppressant Major Business
Table 70. SL PHARM Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 71. SL PHARM SWOT Analysis
Table 72. SL PHARM Organ Transplant Immunosuppressant Product and Services
Table 73. SL PHARM Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Livzon Pharmaceutical Group Inc., Basic Information, Manufacturing Base and Competitors
Table 75. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Major Business
Table 76. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 77. Livzon Pharmaceutical Group Inc., SWOT Analysis
Table 78. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product and Services
Table 79. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Sirio Pharma Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 81. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Major Business
Table 82. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Total Revenue (USD Million) (2018-2019)
Table 83. Sirio Pharma Co., Ltd SWOT Analysis
Table 84. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Product and Services
Table 85. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Organ Transplant Immunosuppressant Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Organ Transplant Immunosuppressant Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Organ Transplant Immunosuppressant Sales by Regions (2015-2020) (K Units)
Table 89. Global Organ Transplant Immunosuppressant Sales Market Share by Regions (2015-2020)
Table 90. Global Organ Transplant Immunosuppressant Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Organ Transplant Immunosuppressant Sales by Countries (2015-2020) (K Units)
Table 92. North America Organ Transplant Immunosuppressant Sales Market Share by Countries (2015-2020)
Table 93. North America Organ Transplant Immunosuppressant Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020)
Table 95. Europe Organ Transplant Immunosuppressant Sales by Countries (2015-2020) (K Units)
Table 96. Europe Organ Transplant Immunosuppressant Sales Market Share by Countries (2015-2020)
Table 97. Europe Organ Transplant Immunosuppressant Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Organ Transplant Immunosuppressant Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Organ Transplant Immunosuppressant Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Organ Transplant Immunosuppressant Sales by Countries (2015-2020) (K Units)
Table 102. South America Organ Transplant Immunosuppressant Sales Market Share by Countries (2015-2020)
Table 103. South America Organ Transplant Immunosuppressant Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Organ Transplant Immunosuppressant Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Organ Transplant Immunosuppressant Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Organ Transplant Immunosuppressant Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020)
Table 109. Global Organ Transplant Immunosuppressant Sales by Type (2015-2020) (K Units)
Table 110. Global Organ Transplant Immunosuppressant Sales Share by Type (2015-2020)
Table 111. Global Organ Transplant Immunosuppressant Revenue by Type (2015-2020) (USD Million)
Table 112. Global Organ Transplant Immunosuppressant Revenue Share by Type (2015-2020)
Table 113. Global Organ Transplant Immunosuppressant Sales by Application (2015-2020) (K Units)
Table 114. Global Organ Transplant Immunosuppressant Sales Share by Application (2015-2020)
Table 115. Global Organ Transplant Immunosuppressant Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Organ Transplant Immunosuppressant Market Share Forecast by Regions (2021-2025)
Table 117. Global Organ Transplant Immunosuppressant Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Organ Transplant Immunosuppressant Market Share Forecast by Type (2021-2025)
Table 119. Global Organ Transplant Immunosuppressant Sales Forecast by Application (2021-2025)
Table 120. Global Organ Transplant Immunosuppressant Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Organ Transplant Immunosuppressant Picture
Figure 2. Global Sales Market Share of Organ Transplant Immunosuppressant by Type in 2019
Figure 3. Tacrolimus Picture
Figure 4. Mycophenolate Mofetil Picture
Figure 5. Cyclosporin Picture
Figure 6. Others Picture
Figure 7. Organ Transplant Immunosuppressant Sales Market Share by Application in 2018
Figure 8. Liver Transplant Picture
Figure 9. Kidney Transplant Picture
Figure 10. Heart Transplant Picture
Figure 11. Other Organ Transplant Picture
Figure 12. Global Organ Transplant Immunosuppressant Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Organ Transplant Immunosuppressant Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Organ Transplant Immunosuppressant Sales Market Share by Manufacturer in 2019
Figure 33. Global Organ Transplant Immunosuppressant Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Organ Transplant Immunosuppressant Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Organ Transplant Immunosuppressant Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Organ Transplant Immunosuppressant Revenue Market Share by Regions (2015-2020)
Figure 40. Global Organ Transplant Immunosuppressant Revenue Market Share by Regions in 2018
Figure 41. North America Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
Figure 42. Europe Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
Figure 44. South America Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020)
Figure 46. North America Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Organ Transplant Immunosuppressant Sales Market Share by Countries (2015-2020)
Figure 48. North America Organ Transplant Immunosuppressant Sales Market Share by Countries in 2018
Figure 49. North America Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2018
Figure 51. United States Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2019
Figure 57. Germany Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Organ Transplant Immunosuppressant Revenue Market Share by Regions 2019
Figure 65. China Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Organ Transplant Immunosuppressant Sales Market Share by Countries in 2019
Figure 72. South America Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2019
Figure 73. Brazil Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Organ Transplant Immunosuppressant Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Organ Transplant Immunosuppressant Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Organ Transplant Immunosuppressant Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Organ Transplant Immunosuppressant Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Organ Transplant Immunosuppressant Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Organ Transplant Immunosuppressant Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Organ Transplant Immunosuppressant Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Organ Transplant Immunosuppressant Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
腎臓移植拒絶治療の世界市場 2020年 Market Overview The global Kidney Transplant Rejection Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidn…- オルガンオンチップの世界市場 2020年 Market Overview The global Organ-on-a-Chip market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 38.2% in the forecast period of 2020 to 2025 and will expected to reach USD 109.6 million by 2025, from USD 30 million in 2019. The Organ-on-a-Chip market r…
- 骨髄移植拒絶反応治療の世界市場 2020年 Market Overview The global Bone Marrow Transplant Rejection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bo…
- 頭皮用マイクロニードルの世界市場 2020年 Market Overview The global Scalp Microneedling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Scalp Microneedling marke…
- 植毛の世界市場 2020年 Market Overview The global Hair Transplantation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hair Transplantation mar…